Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform

OBJECTIVES: With a rapidly growing list of candidate immune‐based cancer therapeutics, there is a critical need to generate highly reliable animal models to preclinically evaluate the efficacy of emerging immune‐based therapies, facilitating successful clinical translation. Our aim was to design and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenoy, Gautam N, Greene, Christopher J, Bhatta, Maulasri, Baroja, Miren L, Loyall, Jenni L, Balu‐Iyer, Sathy V, Kelleher, Raymond J, Carreno, Beatriz M, Linette, Gerald P, Shultz, Leonard D, Bankert, Richard B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853904/
https://www.ncbi.nlm.nih.gov/pubmed/33552509
http://dx.doi.org/10.1002/cti2.1246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853904/
https://www.ncbi.nlm.nih.gov/pubmed/33552509
http://dx.doi.org/10.1002/cti2.1246

Ejemplares similares